company tower banner
Luzerne Recherche et Développement Company Logo

Luzixine™ Powder 300μm - alfalfa extract

1 of 3 products in this brand
LUZIXINE™ is the only concentrated protein extract made from Medicago sativa on the marketUnlike other ingredients derived from Medicago sativa LUZIXINE™ is not a dried leaf mash LUZIXINE™ is extracted from fresh leaf juice, concentrated to maximize the nutritional benefits of Medicago sativa

Ingredient Name: Alfalfa

Functions: Amino Acid, Protein Source, Supplement, Whole Food Ingredient

Ingredient Origin: Natural Origin, Plant Origin, Vegetable Origin

Labeling Claims: Additive-free, Allergen-free, Bio-based, Clean Label, Cold-Pressed, Environmentally Friendly, GMO-free, Gluten-free, Nanomaterials-free, Natural, Naturally Derived, Non-GMO, Not Tested on Animals, Plant-Based, Soy-free, Sustainable, TSE-free, Vegan, Vegetarian

Protein Content: 53.6 - 53.6 %

Certifications & Compliance: EU Novel Foods, FDA Compliant, Vegan

Technical Data Sheet
  • TypeDocument Name
View All Documents

Knowde Enhanced TDS

Identification & Functionality

Ingredient Name

Features & Benefits


LUZIXINE™ is a concentrated source of nutrients including proteins, omega-3, vitamins A, E, K1, B8, B9, and calcium, iron, manganese, and lutein.

LUZIXINE™  represents a protein concentrate of choice given its protein content and the quality of its amino acids:

  • Very high in protein (54% of finished product weight)
  • Contains all essential amino acids
  • Protein digestibility between 70 and 85%
  • Chemical index of 120 and PDCAAS between 0.84 and 1

Applications & Uses


Physical Form
Amino Acids Profile
ValueUnitsTest Method / Conditions
Aspartic Acid5g/100g-
Glutamic Acid5.6g/100g-
Methionine + Cystine1.5g/100g-
Phenylalanine + Tyrosine5.2g/100g-
Typical Properties
ValueUnitsTest Method / Conditions
Microbiological Values
ValueUnitsTest Method / Conditions
Microorganisms mesophilic aerobic (TAMF) (at 30°C)max. 100000 CFU/ gNF EN ISO 4833-1
Clostridium perfringensmax. 10 CFU/ gNF EN ISO 7937
Enterobacteriaceae (at 37°C)max. 100 CFU/ gNF EN ISO 21528-2
Escherichia coli (at 44°C)max. 10 CFU/ gNF EN ISO 16649-2
Listeria monocytogenesAbsent/ 25 gNF EN ISO 11290-1
Presumptive Bacillus cereusmax. 100CFU/ gNF EN ISO 7932
Salmonella sppAbsent/ 25 gNF EN ISO 6579-1
Staphylocoques coagulase positive (at 37°C) max. 100 CFU/ gNF EN ISO 6888-2
Yeasts and Mouldsmax. 1000 CFU/ gNF EN ISO 21527-2
Nutritional Information
ValueUnitsTest Method / Conditions
Minerals Content10.7g/100g-
Salt Content0.24g/100g-
Sugars (Mono and Disaccharides)0.76g/100g-
Typical Fatty Acid Profile
ValueUnitsTest Method / Conditions
Alpha Linolenic Acid (Omega 3)52.3%-
Linoleic and (Omega 6)16.1%-
Mono-insaturated Fatty Acis8.2%-
Oleic Acid7%-
Omega 6/Omega 3 Ratio0.33%-
Palmitic Acid14.2%-
Poly-insaturated Fatty Acids68.7%-
Saturated Fatty Acids22.8%-
Stearic Acid2.9%-
Mineral Profile
ValueUnitsTest Method / Conditions
Calcium Content3328mg/100g-
Copper Content0.76mg/100g-
Iron Content84.4mg/100g-
Magnesium Content148mg/100g-
Manganese Content6.64mg/100g-
Phosphorus Content778mg/100g-
Potassium Content786mg/100g-
Zinc Content1.91mg/100g-
ValueUnitsTest Method / Conditions
Dry Mattermin. 91%EC Dir 152/2009 or Arrêté du 08/09/1977 adapt
Fat Content (Luzixine)9 - 11%EC Dir 152/2009 or NF VO4-402 adapt.
Iron (Luzixine)28.7 - 179.4%EC Dir 152/2009 Fer : - J1043 ICP-OES or - JJ0CJ Fer : ICP-MS or - EN 13805 adapt. or - EN 15763 adapt
Mineral Content (Luzixine)8 - 13%EC Dir 152/2009 Fer : - J1043 ICP-OES or - JJ0CJ Fer : ICP-MS or - EN 13805 adapt. or - EN 15763 adapt
Protein Content (Luzixine)50 - 56%NF EN ISO 16634-1 adapt. or NF V04-407 adapt.
Typical Vitamin Profile
ValueUnitsTest Method / Conditions
A (Beta-Carotene Retinol Eq.)8.42mg/100g-
Vitamin B10.2mg/100g-
Vitamin B120.96μg/100g-
Vitamin B20.24mg/100g-
Vitamin B31.07mg/100g-
Vitamin B51.55mg/100g-
Vitamin B60.5mg/100g-
Vitamin B80.07mg/100g-
Vitamin B90.66mg/100g-
Vitamin D0.47μg/100g-
Vitamin E22.6mg/100g-
Vitamin K10.42mg/100g-

Regulatory & Compliance

Certifications & Compliance

Technical Details & Test Data

Scientific Studies

Scientific studies have been carried out to qualify the efficacy of LUZIXINE™ supplementation. These studies demonstrate the beneficial effects of LUZIXINE™ on:

 Successful thriving:
Two studies were carried out on children in order to compare supplementation with concentrated extract of alfalfa leaf and consumption of powdered milk [1],[2]

 Correction of iron deficiency anemia:
A study was conducted on anemic adolescent girls [3]

Because health is a precious asset for all of us, LUZIXINE™ is also used in the humanitarian context for malnourished populations, among whom it has demonstrated conclusive results. In this respect, LUZIXINE™ legitimately meets the needs of all individuals, particularly those with specific nutritional requirements.

  • [1] APEF Peru 1 study report, Eric Bertin (2006) Nutrition trial evaluating the efficacy and tolerance of use of alfalfa leaf extract as a dietary supplement in children suffering from chronic malnutrition.
  • [2] Study Peru 2, Anonymous. Lucerne leaf concentrate, a possible food supplement for the prevention of chronic malnutrition in children.
  • [3] Swati Vyas, Eric Bertin et al., (2009) Leaf concentrate as an alternative to iron and folic acid supplements for anemic adolescent girls: A randomized controlled trial in India. Public Health Nutrition. 13: 418-423.

Packaging & Availability

Packaging Type
Regional Availability
  • Global
Availability Information

LUZIXINE™ is far more than just an exceptional raw material. It is also an asset for optimizing nutraceutical formulations. LUZIXINE™ can be used as a sole ingredient or in combination in dietary supplement formulas, capsules, tablets, sticks or stand up pouches.

Storage & Handling

Shelf Life
60 months
Storage Information

At room temperature in a dark and dry place, sheltered from air and temperature variations